Published in Pharmacol Biochem Behav on March 01, 1999
Acute and constitutive increases in central serotonin levels reduce social play behaviour in peri-adolescent rats. Psychopharmacology (Berl) (2007) 1.03
Behavioral effects of MDMA ('ecstasy') on adult zebrafish. Behav Pharmacol (2011) 0.89
A developmental comparison of the neurobehavioral effects of ecstasy (MDMA). Neurotoxicol Teratol (2006) 0.88
Study of the behavioural responses related to the potential addictive properties of MDMA in mice. Naunyn Schmiedebergs Arch Pharmacol (2004) 0.85
Validation of a modified mirrored chamber sensitive to anxiolytics and anxiogenics in mice. Psychopharmacology (Berl) (2003) 0.84
Neuroprotective effect of atypical antipsychotics in cognitive and non-cognitive behavioral impairment in animal models. Cell Adh Migr (2009) 0.82
Persistent downregulation of hippocampal CREB mRNA parallels a Y-maze deficit in adolescent rats following semi-chronic amphetamine administration. Br J Pharmacol (2008) 0.82
Treatment with a serotonin-depleting regimen of MDMA prevents conditioned place preference to sex in male rats. Behav Neurosci (2007) 0.80
Preclinical animal anxiety research - flaws and prejudices. Pharmacol Res Perspect (2016) 0.77
The effect of quetiapine (Seroquel™) on conditioned place preference and elevated plus maze tests in rats when administered alone and in combination with (+)-amphetamine. Psychopharmacology (Berl) (2014) 0.76
Behavioral and neurochemical effects of repeated MDMA administration during late adolescence in the rat. Prog Neuropsychopharmacol Biol Psychiatry (2013) 0.75
Behavioral and Stereological Analysis of the Effects of Intermittent Feeding Diet on the Orally Administrated MDMA ("ecstasy") in Mice. Innov Clin Neurosci (2017) 0.75
Decreased pain tolerance and mood in recreational users of MDMA. Psychopharmacology (Berl) (2004) 0.75
Amino acid transmitters in the mammalian central nervous system. Ergeb Physiol (1974) 5.99
GABA, bicuculline and central inhibition. Nature (1970) 3.55
Bicuculline, an antagonist of GABA and synaptic inhibition in the spinal cord of the cat. Brain Res (1971) 3.52
Cellular and synaptic adaptations mediating opioid dependence. Physiol Rev (2001) 3.45
How opioids inhibit GABA-mediated neurotransmission. Nature (1997) 3.09
The hyperpolarization of spinal motoneurones by glycine and related amino acids. Exp Brain Res (1968) 3.00
The lethal effect of mebendazole on secondary Echinococcus granulosus, cysticerci of Taenia pisiformis and tetrathyridia of Mesocestoides corti. Parasitology (1975) 2.97
A pharmacological study of the depression of spinal neurones by glycine and related amino acids. Exp Brain Res (1968) 2.95
Mu and delta receptors belong to a family of receptors that are coupled to potassium channels. Proc Natl Acad Sci U S A (1987) 2.48
Melasma of the arms associated with hormone replacement therapy. Br J Dermatol (1998) 2.45
The specificity of strychnine as a glycine antagonist in the mammalian spinal cord. Exp Brain Res (1971) 2.41
Committee report. Publication recommendations for electrodermal measurements. Psychophysiology (1981) 2.39
Antagonism between bicuculline and GABA in the cat brain. Brain Res (1971) 2.29
Interaction between tetraethylammonium and amino acid residues in the pore of cloned voltage-dependent potassium channels. J Biol Chem (1991) 2.18
The structural specificity of the high affinity uptake of L-glutamate and L-aspartate by rat brain slices. J Neurochem (1972) 2.15
Spinal interneurone excitation by conformationally restricted analogues of L-glutamic acid. Nature (1974) 2.09
GABA uptake in rat central nervous system: comparison of uptake in slices and homogenates and the effects of some inhibitors. J Neurochem (1971) 2.00
Clinical validation of a structural porous tantalum biomaterial for adult reconstruction. J Bone Joint Surg Am (2004) 1.68
Inhibition of GABA uptake in rat brain slices by nipecotic acid, various isoxazoles and related compounds. J Neurochem (1975) 1.67
Do patients refusing transport remember descriptions of risks after initial advanced life support assessment? Acad Emerg Med (1998) 1.66
Presynaptic inhibitory action of opioids on synaptic transmission in the rat periaqueductal grey in vitro. J Physiol (1997) 1.57
Enhanced opioid efficacy in opioid dependence is caused by an altered signal transduction pathway. J Neurosci (1998) 1.54
Excitation of mammalian central neurones by acidic amino acids. Brain Res (1972) 1.52
GABA-Activated ligand gated ion channels: medicinal chemistry and molecular biology. J Med Chem (2000) 1.51
The intraspinal distribution of some depressant amino acids. J Neurochem (1968) 1.46
2-Hydroxy-saclofen: an improved antagonist at central and peripheral GABAB receptors. Neurosci Lett (1988) 1.44
Actions of cannabinoids on membrane properties and synaptic transmission in rat periaqueductal gray neurons in vitro. Mol Pharmacol (2000) 1.43
Hyperpolarization by opioids acting on mu-receptors of a sub-population of rat periaqueductal gray neurones in vitro. Br J Pharmacol (1994) 1.41
Characterization and functional expression of a rat genomic DNA clone encoding a lymphocyte potassium channel. J Immunol (1990) 1.41
Increase by the ORL1 receptor (opioid receptor-like1) ligand, nociceptin, of inwardly rectifying K conductance in dorsal raphe nucleus neurones. Br J Pharmacol (1996) 1.40
Bicuculline methochloride as a GABA antagonist. Nat New Biol (1972) 1.40
Action of the neurotoxin kainic acid on high affinity uptake of L-glutamic acid in rat brain slices. J Neurochem (1979) 1.39
Discovery and characterization of a family of insecticidal neurotoxins with a rare vicinal disulfide bridge. Nat Struct Biol (2000) 1.38
Opioid inhibition of rat periaqueductal grey neurones with identified projections to rostral ventromedial medulla in vitro. J Physiol (1996) 1.38
High affinity uptake of transmitters: studies on the uptake of L-aspartate, GABA, L-glutamate and glycine in cat spinal cord. J Neurochem (1973) 1.37
Biomechanical and clinical evaluations of a porous tantalum implant for the treatment of early-stage osteonecrosis. J Bone Joint Surg Am (2005) 1.33
Structure and biological activity of a series of conformationally restricted analogues of GABA. J Neurochem (1975) 1.32
The inactivation of extracellularly administered amino acids in the feline spinal cord. Exp Brain Res (1970) 1.31
Correlation of the findings of magnetic resonance imaging with those of bone biopsy in patients who have stage-I or II ischemic necrosis of the femoral head. J Bone Joint Surg Am (1989) 1.30
A new class of GABA agonist. Nature (1977) 1.28
Inhibition of the uptake of GABA and related amino acids in rat brain slices by the optical isomers of nipecotic acid. J Neurochem (1976) 1.28
The reproducibility of the Childhood Asthma Questionnaires: measures of quality of life for children with asthma aged 4-16 years. Qual Life Res (1994) 1.27
muO-conotoxin MrVIB selectively blocks Nav1.8 sensory neuron specific sodium channels and chronic pain behavior without motor deficits. Proc Natl Acad Sci U S A (2006) 1.26
Glycine uptake in rat central nervous system slices and homogenates: evidence for different uptake systems in spinal cord and cerebral cortex. J Neurochem (1971) 1.24
Bicuculline and central GABA receptors. Nature (1970) 1.23
gamma-Aminobutyric acid agonists: an in vitro comparison between depression of spinal synaptic activity and depolarization of spinal root fibres in the rat. Br J Pharmacol (1980) 1.23
Nociceptin receptor coupling to a potassium conductance in rat locus coeruleus neurones in vitro. Br J Pharmacol (1996) 1.23
The 'ABC' of GABA receptors: a brief review. Clin Exp Pharmacol Physiol (1999) 1.23
Baclofen: stereoselective inhibition of excitant amino acid release. J Pharm Pharmacol (1980) 1.22
Neuropharmacology of amino acid inhibitory transmitters. Annu Rev Pharmacol Toxicol (1978) 1.20
Acetabular fractures: long-term follow-up of open reduction and internal fixation. J Orthop Trauma (1994) 1.20
Convulsive action of penicillin. Brain Res (1972) 1.19
Inhibition by opioids acting on mu-receptors of GABAergic and glutamatergic postsynaptic potentials in single rat periaqueductal gray neurones in vitro. Br J Pharmacol (1994) 1.18
Single potassium channels opened by opioids in rat locus ceruleus neurons. Proc Natl Acad Sci U S A (1989) 1.18
Central effects of beta-(para-chlorophenyl)-gamma-aminobutyric acid. Brain Res (1974) 1.17
Uptake and release of D- and L-aspartate by rat brain slices. J Neurochem (1976) 1.17
Chalk eating in middle Georgia: a culture-bound syndrome of pica? South Med J (1999) 1.17
Inhibition of spinal neurons by glycine. Nature (1967) 1.17
Actions of the ORL1 receptor ligand nociceptin on membrane properties of rat periaqueductal gray neurons in vitro. J Neurosci (1997) 1.17
Central actions of benzodiazepines. Brain Res (1976) 1.16
Total knee arthroplasty in a group of patients less than 45 years of age. J Arthroplasty (1995) 1.16
Cannabinoid receptor activation inhibits GABAergic neurotransmission in rostral ventromedial medulla neurons in vitro. Br J Pharmacol (1999) 1.15
Enhancement of GABA binding by pentobarbitone. Neurosci Lett (1980) 1.14
Continued morphine modulation of calcium channel currents in acutely isolated locus coeruleus neurons from morphine-dependent rats. Br J Pharmacol (1999) 1.13
Bicuculline-insensitive GABA receptors: studies on the binding of (-)-baclofen to rat cerebellar membranes. Neurosci Lett (1984) 1.13
Betel nut constituents as inhibitors of gamma-aminobutyric acid uptake. Nature (1975) 1.12
The Flexner Report and black medical schools. J Natl Med Assoc (1984) 1.10
Nociceptin inhibits calcium channel currents in a subpopulation of small nociceptive trigeminal ganglion neurons in mouse. J Physiol (2001) 1.10
Neurochemical studies on quinolone antibiotics: effects on glutamate, GABA and adenosine systems in mammalian CNS. Pharmacol Toxicol (1989) 1.09
The structure of a novel insecticidal neurotoxin, omega-atracotoxin-HV1, from the venom of an Australian funnel web spider. Nat Struct Biol (1997) 1.08
Central actions of ibotenic acid and muscimol. Biochem Pharmacol (1968) 1.08
Modulation of Ca2+ channel currents of acutely dissociated rat periaqueductal grey neurons. J Physiol (1998) 1.08
GABA uptake in rat brain slices: inhibition by GABA analogues and by various drugs. J Neurochem (1973) 1.07
Cis- and trans-4-aminocrotonic acid as GABA analogues of restricted conformation. J Neurochem (1975) 1.07
The human toxicity of marijuana. Med J Aust (1994) 1.07
GABA agonists and antagonists. Biochem Pharmacol (1979) 1.07
Red tattoo reactions. Clin Exp Dermatol (2003) 1.06
Muscimol uptake, release and binding in rat brain slices. J Neurochem (1978) 1.06
Are alpha9alpha10 nicotinic acetylcholine receptors a pain target for alpha-conotoxins? Mol Pharmacol (2007) 1.06
Comparison of binding parameters of sigma 1 and sigma 2 binding sites in rat and guinea pig brain membranes: novel subtype-selective trishomocubanes. Eur J Pharmacol (1996) 1.03
Effects of sumatriptan on rat medullary dorsal horn neurons. Pain (2004) 1.03
Glutamate uptake by brain slices and its relation to the depolarization of neurones by acidic amino acids. J Neurobiol (1972) 1.02
Antagonism of neuronal excitation by 1-hydroxy-3-aminopyrrolidone-2. Brain Res (1973) 1.01
Isothiouronium compounds as gamma-aminobutyric acid agonists. Br J Pharmacol (1986) 1.01
Excitotoxin lesions suggest an aspartatergic projection from rat medial prefrontal cortex to ventral tegmental area. Brain Res (1985) 1.01
Identification of functional domains of the human glutamate transporters EAAT1 and EAAT2. J Biol Chem (1998) 1.00
Diazepam enhancement of low affinity GABA binding to rat brain membranes. Neurosci Lett (1982) 1.00
Effects of a naturally occurring neurosteroid on GABAA IPSCs during development in rat hippocampal or cerebellar slices. J Physiol (1999) 0.98
Livedo reticularis induced by amantadine. Br J Dermatol (2003) 0.98
Retrograde signalling by endocannabinoids. Handb Exp Pharmacol (2005) 0.98
Reconstruction of the deficient acetabulum with an oblong prosthesis: three- to seven-year results. J Arthroplasty (1998) 0.98
Inhibition of fatty acid amide hydrolase unmasks CB1 receptor and TRPV1 channel-mediated modulation of glutamatergic synaptic transmission in midbrain periaqueductal grey. Br J Pharmacol (2011) 0.97
Pharmacology of barbiturates: electrophysiological and neurochemical studies. Int Rev Neurobiol (1983) 0.97
Cardiovascular effects of microinjections of opioid agonists into the 'Depressor Region' of the ventrolateral periaqueductal gray region. Brain Res (1997) 0.97
Efficacy and safety of enoxaparin to prevent deep venous thrombosis after hip replacement surgery. Enoxaparin Clinical Trial Group. Ann Intern Med (1994) 0.97
Effects of the Areca nut constituents arecaidine and guvacine on the action of GABA in the cat central nervous system. Brain Res (1977) 0.97
The differential sensitivity of spinal interneurones and Renshaw cells to Kainate and N-methyl-D-aspartate. Exp Brain Res (1974) 0.96
Isolation of a funnel-web spider polypeptide with homology to mamba intestinal toxin 1 and the embryonic head inducer Dickkopf-1. Toxicon (2000) 0.96